UT MD Anderson

UT MD Anderson researchers identified a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly other aggressive prostate cancer subtypes that are difficult to diagnose: spr.ly/6016BBxWkq @JPZhaoMD #EndCancer

The @US_FDA granted accelerated approval to sonrotoclax for some patients with mantle cell lymphoma, based on results from an ongoing trial led by our @michaelwangmd. #EndCancer

One year ago, we announced Kinder Foundation’s historic $150 million gift to create Kinder Children's Cancer Center, a joint venture of @UTMDAnderson and @TexasChildrens. Our collaboration continues to gain momentum as we work together to #EndChildhoodCancer for families like the Janeceks. youtu.be/7-S3gnkFWJQ #UTMDAnderson_TexasChildrens

"This fully oral regimen may substantially improve convenience and quality of life for older newly diagnosed AML patients," says our Dr. Courtney DiNardo. #EndCancer

UT MD Anderson researchers developed a 13-gene panel and a machine learning model that can predict which triple-negative breast cancer patients are more likely to respond to treatment: spr.ly/6011BBvadH @nicholas_navin @clintonyammd #EndCancer

Results from a Phase 2 trial showed that a lower-intensity treatment regimen may be highly effective in some subsets of patients with acute myeloid leukemia. Learn more: spr.ly/6014BBQgAk @tapkadia #EndCancer

The Meyers Institute for Oncology Nursing is equipping nurses with the skills, support and opportunities they need to care for patients today and into the future. When nurses are supported, patients feel the difference. #EndCancer

Our Dr. Xiao Zhao has his sights set on finding more cancers earlier, when they’re easier to treat and patients don’t suffer nearly as many side effects. Read more about his work: spr.ly/6018BBs8R4 @DrXiaoZhao #EndCancer

Today, we celebrate the mothers and mother figures who bring strength, love and comfort to those around them. We also hold close those remembering them today. Happy Mother’s Day from UT MD Anderson. #EndCancer

@ZachRushinwmuv We’re thinking of you, Zach!

Md Anderson, work your magic, run the tests and tell me im still cancer free!

UT MD Anderson researchers found the YAP1 protein is a potential biomarker and therapeutic target to overcome chemotherapy resistance in patients with small cell lung cancer. Learn more: spr.ly/6010BBd5QE #EndCancer

We’ve got your sun safety covered. Stop by any of the five @UTMDAnderson sunscreen stations on the golf course, apply generously, and remember to reapply every two hours. UV rays damage your skin even on cloudy days. #EndCancer

Results of a Phase 1/2 trial found the targeted RAS inhibitor therapy daraxonrasib demonstrated the potential to improve patient outcomes for patients with RAS-mutant pancreatic cancer: spr.ly/6013BBcmuL @davidhongmd #EndCancer

A new study found that levels of commonly measured serum tumor markers can play a significant role in predicting outcomes in some patients with appendiceal adenocarcinoma: spr.ly/6014BBd5Yy @jpshen_md #EndCancer

Researchers have identified specific genomic biomarkers that distinguish inflammatory breast cancer from other subtypes, providing potentially transformative diagnosis and treatment insights for patients with this aggressive disease: spr.ly/6017BBgqHz #EndCancer

Early detection for bladder cancer is crucial, and in our latest Cancerwise podcast episode, Drs. Ashish Kamat and Matt Campbell discuss the signs to look for. Listen to the full episode: spr.ly/6010BBgD4g @docmattcampbell @urodocash #EndCancer

To our nurses, we are grateful for your compassionate care you provide every day. This #NursesWeek, we honor your dedication to our patients and their families. #EndCancer

Researchers are using advanced imaging to view cancer environments in 3D. At the James P. Allison Institute Hackathon, teams are accelerating this kind of innovation, turning complex data into insights that could shape future treatments for hard-to-treat cancers. #EndCancer

UT MD Anderson researchers identified a key enzyme – RNase H2 – that helps triple-negative breast cancer cells survive high levels of DNA replication stress. How these results suggest RNase H2 is a promising treatment target: spr.ly/6012BBwyGn #EndCancer

Some of the same brain changes seen in Alzheimer’s disease can also happen during cancer treatment, including “chemobrain.” By studying these overlaps, scientists are working to better protect brain health and improve future treatments. @jimrayndc #EndCancer